Pastore, Nunzia http://orcid.org/0000-0002-8701-5592
Huynh, Tuong
Herz, Niculin J.
Calcagni’, Alessia http://orcid.org/0000-0002-1946-5815
Klisch, Tiemo J.
Brunetti, Lorenzo http://orcid.org/0000-0003-2624-8576
Kim, Kangho Ho
De Giorgi, Marco
Hurley, Ayrea
Carissimo, Annamaria
Mutarelli, Margherita
Aleksieva, Niya http://orcid.org/0000-0002-7887-5494
D’Orsi, Luca
Lagor, William R.
Moore, David D. http://orcid.org/0000-0002-5151-9748
Settembre, Carmine
Finegold, Milton J.
Forbes, Stuart J.
Ballabio, Andrea http://orcid.org/0000-0003-1381-4604
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01-NS078072)
Associazione Italiana per la Ricerca sul Cancro (IG 2015-176339)
Fondazione Telethon
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIH-P30DK58338)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI-CA125123)
Article History
Received: 8 January 2020
Accepted: 20 April 2020
First Online: 18 May 2020
Competing interests
: A.B. is a co-founder of CASMA Therapeutics, Boston, MA, USA. The remaining authors declare no competing interests.